Rallybio
Price & Volume
Stats
See moreOpen | $16.01 |
Previous Close | $15.95 |
Day Range | $15.94-$16.01 |
52W Range | $3.20-$17.57 |
Market Cap | $84.5M |
Shares Short | 170,156 |
Financials
See moreRevenue (12 Mos) | $858,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$14.6M |
Diluted EPS | -$1.36 |
News
See moreYahoo Finance • last month
VERAXA Biotech Expands R&D Hub in Heidelberg as Programs Advance Towards Clinical Development
Yahoo Finance • last month
Prolium Bioscience Sclerosis, Lupus Treatment Studies Advancing
Yahoo Finance • 2 months ago
Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSK
Yahoo Finance • 2 months ago
Top Biotech Gainers: TTRX Turns Heads, LIXT Shifts To AI Energy, CNXU Update, QTRX, TRAX On Watch
About
CEO | Dr. Stephen Uden M.D., MBBS |
CFO | Mr. Jonathan I. Lieber M.B.A. |
Address | 234 Church Street, New Haven, CT, United States, 06510 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |